21Shares Expands its European Lineup with the Launch of Three Innovative Physically-Backed Crypto ETPs on Euronext Paris and Euronext Amsterdam
21Shares Immutable ETP (AIMX), 21Shares Injective Staking ETP (AINJ) and 21Shares Sui Staking ETP (ASUI) reflect significant advancements in crypto innovation and investing
ZURICH, 10 July 2024 – 21Shares AG (“21Shares”), one of the world’s largest issuers of crypto exchange traded products (ETPs), today announced the launch of the 21Shares Immutable ETP (AIMX), the 21Shares Injective Staking ETP (AINJ) and the 21Shares Sui Staking ETP (ASUI) on Euronext Paris and Euronext Amsterdam. AIMX, AINJ and ASUI represent the latest additions to 21Shares’ growing European product lineup of physically backed crypto ETPs, which offers investors exposure to underlying crypto assets through their existing bank or brokerage.
Product Name | Ticker | ISIN | Fee |
21Shares Immutable ETP | AIMX | CH1360612142 | 2.5% |
21Shares Injective Staking ETP | AINJ | CH1360612134 | 2.5% |
21Shares Sui Staking ETP | ASUI | CH1360612159 | 2.5% |
These launches bring the 21Shares European product lineup to 43 crypto-asset ETPs and over $3.3bn in total assets under management (AUM). The new products harness 21Shares’s six years of experience developing, issuing and managing crypto asset ETPs for investors across Europe and around the globe.
“The world of decentralized finance (DeFi) is constantly evolving, as technological innovation has continued to move at a rapid clip. Meanwhile, investors are expressing ongoing interest in gaining exposure to new blockchain technologies, platforms and protocols,” said Hany Rashwan, Co-Founder and CEO of 21Shares. “With these latest launches, 21Shares is continuing to expand its industry-leading crypto asset ETP offering to include exposure to three innovative blockchain ecosystems: Immutable, Injective and Sui.”
21Shares Immutable ETP (AIMX)
The 21Shares Immutable ETP (AIMX), 100% physically-backed, tracks the performance of IMX, offering investors exposure to the growing industries of gaming and digital collectibles. Immutable is a leading blockchain gaming platform that revolutionizes the gaming experience, offering over 200+ blockchain-based games and multiple NFT marketplaces, all while ensuring speed and affordability. By leveraging two innovative scaling solutions, Immutable bypasses Ethereum’s limitations, providing a seamless, low-cost environment for both developers and gamers. With strategic partnerships, including industry giant Ubisoft, and robust developer support, Immutable is poised to dominate the crypto gaming market, making it an attractive opportunity for investors seeking to tap into this industry.
21Shares Injective Staking ETP (AINJ)
100% physically-backed, the 21Shares Injective Staking ETP (AINJ) tracks the performance of INJ while capturing staking yields that are reinvested into the ETP for enhanced performance. Whereas blockchain networks are typically siloed, Injective Protocol supports seamless interactions across major networks, enabling a unique range of financial products and services. The 21Shares Injective Staking ETP offers a simple, regulated, and transparent way to benefit from the network’s growing importance in decentralized finance (DeFi).
21Shares Sui Staking ETP (ASUI)
Sui is a permissionless, Proof of Stake powered Layer 1 blockchain designed for instant settlement, high transaction throughput, and reduced latency in smart contract deployment. It supports a thriving ecosystem of decentralized applications (dApps) including DeFi and GameFi, facilitated by its unique ability to scale while leveraging parallel processing to maintain low costs and high efficiency. 100% physically-backed by SUI tokens, the 21Shares Sui Staking ETP (ASUI) tracks the performance of SUI, while capturing staking yields that are reinvested into the ETP for advanced performance, to offer a simple, regulated, and transparent way for investors to gain exposure to the Sui blockchain.
Press Contact:
21Shares: Audrey Belloff, audrey.belloff@21.co
About 21.co / 21Shares:
21.co is the world’s leader in providing access to crypto through simple and easy to use products. 21.co is the parent company of 21Shares, one of the world’s largest issuers of crypto exchange traded products (ETPs) – which is powered by Onyx, a proprietary technology platform used to issue and operate cryptocurrency ETPs for 21Shares and third parties. The company was founded in 2018 by Hany Rashwan and Ophelia Snyder. 21Shares is registered in Zurich, Switzerland with offices in Zurich, London and New York. For more information, please visit 21Shares.
DISCLAIMER
This document is not an offer to sell or a solicitation of an offer to buy or subscribe for securities of 21Shares AG in any jurisdiction. Neither this document nor anything contained herein shall form the basis of, or be relied upon in connection with, any offer or commitment whatsoever or for any other purpose in any jurisdiction. Nothing in this document should be considered investment advice.
This document and the information contained herein are not for distribution in or into (directly or indirectly) the United States, Canada, Australia or Japan or any other jurisdiction in which the distribution or release would be unlawful.
This document does not constitute an offer of securities for sale in or into the United States, Canada, Australia or Japan. The securities of 21Shares AG to which these materials relate have not been and will not be registered under the United States Securities Act of 1933, as amended (the “Securities Act”), and may not be offered or sold in the United States absent registration or an applicable exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. There will not be a public offering of securities in the United States. Neither the US Securities and Exchange Commission nor any securities regulatory authority of any state or other jurisdiction of the United States has approved or disapproved of an investment in the securities or passed on the accuracy or adequacy of the contents of this presentation. Any representation to the contrary is a criminal offence in the United States.
Within the United Kingdom, this document is only being distributed to and is only directed at: (i) to investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the “Order”); or (ii) high net worth entities, and other persons to whom it may lawfully be communicated, falling within Article 49(2)(a) to (d) of the Order (all such persons together being referred to as “relevant persons”); or (iii) persons who fall within Article 43(2) of the Order, including existing members and creditors of the Company or (iv) any other persons to whom this document can be lawfully distributed in circumstances where section 21(1) of the FSMA does not apply. The securities are only available to, and any invitation, offer or agreement to subscribe, purchase or otherwise acquire such securities will be engaged in only with, relevant persons. Any person who is not a relevant person should not act or rely on this document or any of its contents.
Exclusively for potential investors in any EEA Member State that has implemented the Prospectus Regulation (EU) 2017/1129 the Issuer’s Base Prospectus (EU) is made available on the Issuer’s website under www.21Shares.com.
The approval of the Issuer’s Base Prospectus (EU) should not be understood as an endorsement by the SFSA of the securities offered or admitted to trading on a regulated market. Eligible potential investors should read the Issuer’s Base Prospectus (EU) and the relevant Final Terms before making an investment decision in order to understand the potential risks associated with the decision to invest in the securities. You are about to purchase a product that is not simple and may be difficult to understand.
This document constitutes advertisement within the meaning of the Prospectus Regulation (EU) 2017/1129 and the Swiss Financial Services Act (the “FinSA”) and not a prospectus. The 2023 Base Prospectus of 21Shares AG has been deposited pursuant to article 54(2) FinSA with SIX Exchange Regulation AG in its function as Swiss prospectus review body within the meaning of article 52 FinSA. The 2023 Base Prospectus and the key information document for any products may be obtained at 21Shares AG’s website (https://21shares.com/ir/prospectus or https://21shares.com/ir/kids).
###